Apollomics(us:APLM)

7.00

+12.90%

Updated on 2025-04-02

Open:6.50
Close:7.00
High:7.88
Low:6.50
Prev Close:6.20
Volume:73212.00
Turnover:523440.56
Turnover Ratio:6.64%
Shares:1.10M
MarketCap:7.72M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-03-3117962126910.75%416
2023-12-311788501639.89%625
2023-09-30121846739320.64%413
2023-06-301214075301.57%404
2023-03-314613691641.58%5139
2022-12-31421014721675.57%568
2022-09-3037982124473.14%345
2022-06-3037936522469.75%583
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Orbimed Advisors Llc85654569.57%0
2024-03-31Exchange Traded Concepts, Llc3876090.43%351936986.56%
2024-03-31Boothbay Fund Management, Llc3737150.42%373715
2024-03-31Powell Investment Advisors, Llc1302970.15%130297
2024-03-31Geode Capital Management, Llc572240.06%0
2024-03-31Bensler, Llc250880.03%0
2024-03-31George Kaiser Family Foundation249840.03%0
2024-03-31Commonwealth Equity Services, Llc200000.02%0
2024-03-31Jane Street Group, Llc190720.02%19072
2024-03-31Warberg Asset Management Llc100260.01%10026

About

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Address:989 East Hillsdale Boulevard,Suite 220

Market Movers